共 41 条
[31]
Nandakumar A., Anantha N., Venugopal T.C., Sankaranarayanan R., Thimmasetty K., Et al., Survival in breast cancer: A population-based study in Bangalore, India, Int J., Cancer, 60, pp. 593-596, (1995)
[32]
Nayak B.K., Das B.R., Differential binding of nuclear proteins to the TP53 gene promoter in male breast tumour, Eur. J. Cancer, 33, pp. 1484-1487, (1997)
[33]
Nayak B.K., Das B.R., Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours, Mol. Biol. Rep, 26, pp. 223-230, (1999)
[34]
Nayak B.K., Das B.R., Mutation and methylation status of p53 gene promoter in human breast tumours, Tumour Biol, 20, pp. 341-346, (1999)
[35]
Nayak B.K., Baral R.N., Das B.R., p53 gene mutation in relation to p53 protein accumulation in male and female breast cancer, Neoplasma, 43, pp. 305-310, (1996)
[36]
Nayak B.K., Patnaik S., Das B.R., Rearrangement of the p53 gene in human breast tumours, Biochem. Biophys. Res. Commun, 245, pp. 388-391, (1998)
[37]
Papadakis E.N., Dokianakis D.N., Spandidos D.A., P53 codon 72 polymorphism as a risk factor in the development of breast cancer, Mol. Cell Biol. Res. Commun, 3, pp. 389-392, (2000)
[38]
Peng Y., Chen L., Li C., Lu W., Chen J., Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization, J. Biol. Chem, 276, pp. 40583-40589, (2001)
[39]
Sambrook J., Russell D.W., Molecular Cloning: A Laboratory Manual. 3rd Edn, (2001)
[40]
Sharma R.G., Ajmera R., Saxena O., Cancer profile in eastern Rajasthan, Indian J. Cancer, 31, pp. 160-173, (1994)